ERBB2 and cancer: Initial cancer vaccination strategies targeted antigens linked to oncogenesis and cancer progression that are shared by many cancers — either overexpressed cancer-initiating gene products (driver antigens) such as HER-2 or reactivated gene products such as MAGE (1, 2).